Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|June 30, 2021
SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United KingdomShirley L Smith, Enyia R Anderson, Cintia Cansado-Utrilla, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2024
Enrichment of SARS-CoV-2 sequence from nasopharyngeal swabs whilst identifying the nasal microbiomeAbdulrahman Alrezaihi, Rebekah Penrice-Randal, Xiaofeng Dong, et al.
Msphere|May 2, 2022
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other LineagesTessa Prince, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Genome Medicine|July 16, 2024
SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infectionHannah Goldswain, Rebekah Penrice-Randal, I'ah Donovan-Banfield, et al.
NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.
Gigascience|May 31, 2022
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiersXiaofeng Dong, Rebekah Penrice-Randal, Hannah Goldswain, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Genome Biology|March 14, 2023
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infectionHannah Goldswain, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
Pageof 3